EUVIMEDEUVIMED entdecken
Crossref

Identification of N6-Methyladenosine-Associated lncRNAs and Analysis of Prognostic Signature in Breast Cancer

Yun Gu, Min Xu, Wangfei Wu, Zhifang Ma, Weiguang Liu

Biochemical Genetics · 2025

DOI: 10.1007/s10528-024-10889-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Genetics, 2025. Verfasst von Yun Gu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Nanjing Women and Children's Healthcare Hospital, Women's Hospital of Nanjing Medical University, Tianfei Road 123th, Nanjin…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Breast Neoplasms, Adenosine, Biomarkers, Tumor. Die Arbeit nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer represents the predominant malignant neoplasm in women, posing significant threats to both life and health. N6-methyladenosine (m6A) methylation, the most prevalent RNA modification, plays a crucial role in cancer development. This study aims to delineate the prognostic implications of m6A-associated long non-coding RNAs (m6AlncRNAs) and identify potential m6AlncRNA candidates as novel therapeutic targets for breast cancer. Through univariate Cox, Least Absolute Shrinkage and Selection Operator and multiple Cox regression analysis, m6AlncRNA was analyzed and a risk-prognosis model was constructed. Kaplan-Meier analysis, principal component analysis and nomogram were used to evaluate the risk model. Finally, we screened candidate lncRNAs and validated them in breast cancer cell lines. m6AlncRNAs were stratified into three subtypes, and their associations with survival outcomes and immune infiltrating capacities were systematically analyzed. Subsequently, breast cancer patients were stratified into high and low-risk groups based on median risk scores, revealing distinct clinical characteristics, tumor immunoinvasive profiles, tumor mutation burden, and survival probabilities. Additionally, a prognostic model was established, highlighting three promising candidate lncRNAs: ECE1-AS1, NDUFA6-DT, and COL4A2-AS1. This study investigated the prognostic implications of m6A-associated long non-coding RNAs (m6AlncRNAs) and developed a prognostic risk model to identify three potential m6AlncRNA candidates. These findings provide valuable insights into the potential application of these m6AlncRNAs in guiding immunotherapeutic strategies for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingBreast NeoplasmsAdenosineBiomarkers, TumorHumansFemalePrognosisGene Expression Regulation, NeoplasticCell Line, TumorMiddle AgedNomograms

Stichwörter der Autor:innen

Breast cancerPrognosis signaturelncRNAsm6A

Substanzen

RNA, Long NoncodingN-methyladenosineAdenosineBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Nanjing Women and Children's Healthcare Hospital, Women's Hospital of Nanjing Medical University, Tianfei Road 123th, Nanjing, 210004, Jiangsu, China.
  • Department of Pathology, Nanjing Women and Children's Healthcare Hospital, Women's Hospital of Nanjing Medical University, Tianfei Road 123th, Nanjing, 210004, Jiangsu, China. mzfhj522@163.com.
  • Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA. wliu17@mdanderson.org.

Zitieren

APA

Gu, Y., Xu, M., Wu, W., Ma, Z., & Liu, W. (2025). Identification of N6-Methyladenosine-Associated lncRNAs and Analysis of Prognostic Signature in Breast Cancer. Biochemical Genetics. https://doi.org/10.1007/s10528-024-10889-0

Vancouver

Gu Y, Xu M, Wu W, Ma Z, Liu W. Identification of N6-Methyladenosine-Associated lncRNAs and Analysis of Prognostic Signature in Breast Cancer. Biochemical Genetics. 2025. doi:10.1007/s10528-024-10889-0

BibTeX
@article{Gu2025,
  author = {Gu, Yun and Xu, Min and Wu, Wangfei and Ma, Zhifang and Liu, Weiguang},
  title = {Identification of N6-Methyladenosine-Associated lncRNAs and Analysis of Prognostic Signature in Breast Cancer},
  journal = {Biochemical Genetics},
  year = {2025},
  doi = {10.1007/s10528-024-10889-0}
}
Kostenlos starten →